TickerFactsScreenerDevelopers

Xenetic Biosciences, Inc. (XBIO) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2012: -$6.26M2013: -$6.05M2016: -$8.79M2017: $1.49M2018: -$6.46M2019: -$6.40M2020: -$4.27M2021: -$4.74M2022: -$4.65M2023: -$4.11M2024: -$2.82M2025: -$2.29M-$2.29M
2012Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$2.29M+18.8%
2024-$2.82M+31.5%
2023-$4.11M+11.5%
2022-$4.65M+1.9%
2021-$4.74M-11.0%
2020-$4.27M+33.3%
2019-$6.40M+1.0%
2018-$6.46M-532.6%
2017$1.49M+117.0%
2016-$8.79M—
2013-$6.05M+3.4%
2012-$6.26M—